We aim to transform how miRNAs are detected, providing simpler tools for health care and drug development professionals.
DestiNA Genomics has raised $2.6M in total funding. The most recent round was Grant. The last funding was announced in November 2025.
DestiNA Genomics's investors include European Innovation Council, Old College Capital, Vitro Group, Scottish Investment Bank.
DestiNA Genomics is headquartered in Edinburgh, United Kingdom.
We aim to transform how miRNAs are detected, providing simpler tools for health care and drug development professionals.
DestiNA Genomics is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"DestiNA Genomics — Funding & Investors." VCBacked, November 27, 2025, https://www.vcbacked.co/company/destina-genomics. Accessed October 29, 2026.
VCBacked. (2025). DestiNA Genomics — Funding & Investors. Retrieved October 29, 2026, from https://www.vcbacked.co/company/destina-genomics
{{cite web |title=DestiNA Genomics — Funding & Investors |url=https://www.vcbacked.co/company/destina-genomics |website=VCBacked |access-date=October 29, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated